Innovent Biologics Inc. (IVBXF)
OTC: IVBXF
· Real-Time Price · USD
12.25
0.12 (0.95%)
At close: Sep 26, 2025, 3:20 PM
12.20
-0.41%
Pre-market: Sep 25, 2025, 09:32 AM EDT
Innovent Biologics Revenue
Innovent Biologics reported an annual revenue of $9.42B, reflecting a 51.82% growth. For the quarter ending December 31, 2024, Innovent Biologics generated $5.47B in revenue.
Revenue (ttm)
9.42B
Revenue Growth
51.82%
Price / Sales Ratio
5.5
Revenue / Employee
1.66M
Employees
5,659
Market Cap
20.94B
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 9.42B | +51.82% |
| Dec 31, 2023 | 6.21B | +36.21% |
| Dec 31, 2022 | 4.56B | +6.71% |
| Dec 31, 2021 | 4.27B | +11.08% |
| Dec 31, 2020 | 3.84B | +266.94% |
| Dec 31, 2019 | 1.05B | +10953.34% |
| Dec 31, 2018 | 9.48M | -48.88% |
| Dec 31, 2017 | 18.54M | -42.30% |
| Dec 31, 2016 | 32.13M | n/a |